CLINICAL ESTABLISHMENTS
Lord’s Mark strengthens UK and UK allied market strategy with regulatory backing for IVD portfolio.
In an exciting development, Lord's Mark Industries has secured registration for its In-Vitro Diagnostic portfolio with the MHRA, significantly boosting market access. This follows the approval of their AI-enhanced Renalyx haemodialysis system in the UK. The firm aims for a December 2026 market launch for its IVD products, ahead of schedule, along with a planned January 2027 start for its pathology lab, highlighting its strong commitment to global healthcare integration.
Russia plague news: What to know about the disease and which countries have been affected as lab worker dies in Siberia?
At the Irkutsk Anti-Plague Research Institute, a tragic incident led to the death of a 28-year-old woman, suspected to have contracted pneumonic plague from live bacteria. This alarming development has prompted local health authorities to place nearly 200 individuals who interacted with her under medical observation. While the exact cause of death remains unconfirmed, hospitals are implementing necessary quarantine measures as investigations continue in light of fluctuating global plague cases.
Ayush services sector supports 1.76 million livelihoods; women constitute 43% of the workforce
The Ayush services sector supports 1.76 million livelihoods in India and has a significant female workforce. Women's participation in organized segments, including hospitals, exceeds 50 percent in several areas. The sector has the potential to expand substantially, generating an estimated USD 216-318 billion by 2047. Ayurveda remains the largest individual system of revenue generation within the sector, contributing significantly.
Mental health answers are hiding inside stomach? Nearly 7 in 10 psychiatric patients found to have same surprising pattern
A large study involving nearly 700,000 adults has uncovered a striking connection between psychiatric disorders and another part of the body that is often overlooked when discussing mental health. Researchers found that people with psychiatric conditions showed a much higher prevalence of a particular group of chronic health problems, with the strongest association seen in one category. The findings add to growing research into a two-way connection that could change how doctors look at mental and physical health.
Meet world’s richest woman: Alice Walton got $33 billion richer without running Walmart, is building a $250 million tuition-free medical school
Alice Walton, the world’s richest woman and Walmart heiress, saw her fortune rise by $33 billion in one year even though she does not run the retail giant. Instead, the 76-year-old billionaire has focused on philanthropy, art and healthcare. She founded a medical school in Bentonville and donated $250 million to support it.
Dr Mark Fowler, who failed to inject Tony Carruthers with a lethal dose at Riverbend Maximum Security Institution Prison in May, set to overseeing Christa Pike's planned execution
Christa Pike execution: The physician responsible for overseeing the planned execution of Christa Pike, a 50-year-old woman sentenced to death for a chilling crime in 1995, was involved in an incident earlier. The day, September 30, 2026, could become a pivotal point for Tennessee as Governor Bill Lee has denied Christa's clemency plea. However, her defense team has made an urgent last-ditch effort to appeal for mercy before the US Supreme Court.
- Go To Page 1
Where Does China Fit in Your Company’s Innovation Strategy?
For decades, multinationals treated China primarily as either a vast growth market or a rising competitive threat. But as growth slows, competition intensifies, and operating conditions become more difficult, many firms are rethinking China’s role. Increasingly, they are using the country not just as a destination market but as a platform for accelerating innovation—leveraging its fast-moving regulatory environment, tightly integrated R&D and manufacturing ecosystems, and deep engineering talent pools to speed learning, validate technologies, and scale capabilities globally. Companies including Pfizer, Michelin, BMW, Bosch, and Nvidia illustrate how firms are using China to shorten innovation cycles while managing geopolitical and operational risks by defining China’s precise role within their global innovation system, designing for controlled knowledge-sharing, and avoiding overdependence through diversified R&D and supply chains.
2026 Nobel Prize Predictions: From GLP-1 drugs and CAR-T therapy to gene editing, these breakthroughs could take centre stage
Predictions for the 2026 Nobel Prizes in science highlight significant contributions in areas like GLP-1 research and cancer therapies. Carl June is mentioned for his role in developing CAR-T cell therapy for cancer treatment. Researchers Emmanuel Mignot and Masashi Yanagisawa are noted for their work on orexin related to sleep regulation. Optical coherence tomography and lipid nanoparticle technology are also strong candidates for recognition.
Lord’s Mark secures MHRA registration for dialysis device, plans UK expansion
Lord's Mark Industries Limited has successfully secured regulatory registration from the MHRA for its innovative haemodialysis machine, paving the way for its expansion in the UK's healthcare technology sector. With plans to commence exports in January 2027 and potentially establish its own dialysis centres, this milestone signifies a crucial step towards creating a comprehensive renal-care ecosystem, manufactured by Renalyx Health Systems Pvt. Ltd. for both institutional and home usage.
What glucosamine may be doing inside the brain has scientists taking a closer look at its possible link to dementia progression
Researchers at the University of Florida found links between glucosamine use and higher dementia progression in individuals with mild cognitive impairment. The study analyzed electronic health records and reported statistical associations but did not prove causation. In experiments with mice, glucosamine increased sugar attachment to proteins, negatively impacting memory performance. Analysis of human brain samples revealed similar protein sugar patterns in Alzheimer's patients.
India’s healthcare AI opportunity could become the next big investment story
The digital rails are ready. India now needs patient capital and founders ambitious enough to build on them.
Ayush services sector growing fast; projected to hit up to USD 318 billion by 2047: Study
The Ayush services sector is projected to reach USD 216-318 billion by 2047 as it continues to expand. This sector reported a 16.91 percent compound annual growth rate since 2022-23 and supported 1.76 million livelihoods. Clinics and day-care centers generated the majority of the sector's revenue, with Ayurveda leading individual systems. The sector's role in Medical Value Travel is also notable with international patients contributing substantially to revenues.
FDA Panel votes in favor of a $949 Cancer detecting blood test, but is Galleri ready for approval?
Cancer cells can leave tiny fragments of DNA in the bloodstream. According to USA Today, Galleri studies chemical patterns found on these fragments. A machine-learning system then analyzes the results for signals that could point to cancer.
Lord’s Mark advances AI breast cancer screening towards clinical trials
In a groundbreaking collaboration with C-MET, Lord's Mark Industries Limited is making strides in breast cancer screening technology. Utilizing advanced AI and thermal sensors, they are set to launch trials in the USA, Great Britain, and Europe. The promising results from clinical trials in India indicate a strong potential for regulatory approval, with plans to enhance affordability and access for underserved communities ahead of anticipated final trials in January 2027.
Brahma AI targets global scale with $2 billion valuation, Silicon Valley push
Brahma AI is set to expand its presence in Silicon Valley, moving into various sectors including sports and healthcare. The company aims to create a global technology business without a conventional headquarters. Significant technological development and R&D will occur in India, ensuring the country remains central to its strategy.
GLP-1 users are suing over vision loss: What does the evidence really show?
Dozens of patients have taken legal action against drug manufacturers, filing personal injury lawsuits that allege they were not adequately warned about the risk of a rare type of sudden vision loss, ABC News reported.
What if your eyes are older than you are? Scientists use a new AI model to uncover a surprising link between retinal age, smoking and diabetes
A new artificial intelligence model can predict age based on retinal images. The model has identified a retinal age gap associated with health and lifestyle factors. People with certain conditions showed a higher retinal age gap in the study. Researchers emphasize the need for further studies to validate the model's reliability for individual assessments. Ultimately, the technology could provide insights into general health through retinal examinations.
Pressure cooker mistake: Doctor says this dangerous habit could be causing more health problems than outside food
A pressure cooker’s rubber gasket is often overlooked during routine cleaning, despite regular exposure to steam, moisture and food residue. A social media post by homeopathic oncology practitioner Dr Tarang Krishna has highlighted the importance of removing and cleaning the gasket separately. While some health claims in the post require independent verification, regular cleaning, proper drying and timely replacement can help maintain pressure cooker hygiene and performance.
Humans may be transmitting hepatitis B virus to Amazon monkeys, raising questions about deforestation and disease spillover
A groundbreaking study has revealed the presence of Hepatitis B virus in wild New World primates in the Amazon. This alarming discovery points to a possible spillover from humans to these animals. Researchers found that the infection rates surged in regions marked by high human activity.
Ichor Biologics seeks $80-100 million PE funding for minority stake sale
Ichor Biologics is seeking eighty to one hundred million dollars from private equity investors. The Hyderabad-based company operates in the specialized plasmatherapy segment. Promoters Ananda Reddy Sudini and Sujana Sudini hold significant stakes in the firm. Ichor manufactures therapeutic protein products derived from human plasma. The company's products serve various critical therapeutic areas.
Millions take calcium and vitamin D to protect their bones. The biggest review yet suggests the daily pills may not prevent the falls they fear most
A large analysis of 69 trials found little benefit from supplements. Calcium and vitamin D do not significantly prevent fractures or falls. This evidence applies to most community-dwelling adults without high risk. Exercise and home safety measures may help reduce falls more effectively. Consult a doctor before changing any supplement regimen.
Gaurav, 10-year-old Namibian cheetah, dies at Kuno National Park: Rescued from the wild after showing weakness, muscle wasting and dehydration
Ten-year-old Namibian cheetah Gaurav died at Madhya Pradesh's Kuno National Park on Monday while undergoing treatment after being rescued from the wild on September 12 in a weak and dehydrated condition. Officials suspected an underlying chronic condition, but the exact cause of death will be determined through a postmortem examination and sample analysis. Following his death, Kuno has 51 cheetahs, including 36 Indian-born, while India's total cheetah population stands at 55.
Presley Gerber spoke candidly about facing what he’d ‘been running from’ just months before death at 27: ‘I was absolutely terrified’
Presley Gerber had opened up about his addiction and recovery journey months before his death at 27. Gerber shared footage of himself at a wellness clinic in Cancun, Mexico, in March where he took part in a ritual and prayer. In a deeply personal post, Cindy Crawford’s son described facing what he had “been running from” while undergoing treatment in Mexico.
Aragen steps up investment in complex drug modalities; plans 500 KL new CDMO capacity
Aragen Life Sciences is increasing investments in complex drug modalities and manufacturing. The company plans to add significant small-molecule CDMO capacity and a biologics facility. Aragen aims to transition from a molecules company to a medicines company through expansion. This strategic move aligns with global drugmakers seeking supply chain alternatives outside China. The firm is also developing its own intellectual property around antibody-drug conjugates.
ENTOD Pharmaceuticals secures patent for its insulin eye drop
Currently at the pre-clinical stage of development, the patented insulin eye drops are being investigated as a potential novel therapeutic approach to address unmet needs in ophthalmic care, the Mumbai-based company said.
Dentist didn't inform root canal risks, patient had to take second treatment after suffering pain; Court orders doctor to pay Rs 2 lakh
A Delhi consumer commission has ordered a dentist to pay Rs 2 lakh to a woman who paid Rs 1.10 lakh for root canal treatment, crowns and veneers and later underwent corrective dental treatment costing Rs 1.38 lakh after experiencing pain and other problems. The commission did not find medical negligence but held that the dentist failed to establish informed consent and proper treatment documentation.
Health ministry issues advisory against unregulated stem cell therapies, restricts autism treatment to approved clinical trials
The Union health ministry issued an advisory against unregulated stem cell therapies. Therapeutic use of stem cells for autism is restricted to approved clinical trials. This advisory reiterates the existing framework governing stem cell research and therapy. It aligns with a Supreme Court ruling restricting unproven stem cell treatments. States and union territories must ensure strict compliance with the applicable framework.
Health Ministry issues advisory clamping down on unregulated use of stem cell therapies
The Union Health Ministry has tightened oversight of stem cell therapies, warning against their unregulated use and making clear that they can be offered as standard treatment only for Ministry-approved conditions.
Agonisingly slow clinical trial is stopping Indian pharma become global innovator from supplier
India's regulatory hurdles slow down early-stage drug trials significantly. This complexity causes Indian companies to conduct crucial first-in-human studies abroad. Other nations like the US and Australia offer faster approval processes for trials. China now leads in novel medicine development due to its streamlined regulatory environment. Reforming India's system can unlock its potential in novel drug innovation.
Load More
